Cargando…
miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α
Resistance to chemotherapy is a primary problem for the effective treatment of ovarian cancer. Recently, increasing evidence has demonstrated that miRNAs modulate many important molecular pathways involved in chemotherapy. Previous studies demonstrated that miR-199a affected ovarian cancer cell resi...
Autores principales: | Feng, Xue, Liu, Ning, Deng, Suo, Zhang, Dandan, Wang, Kexin, Lu, Meisong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731338/ https://www.ncbi.nlm.nih.gov/pubmed/29276393 http://dx.doi.org/10.2147/OTT.S145833 |
Ejemplares similares
-
Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α
por: Keremu, Ajimu, et al.
Publicado: (2019) -
Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma
por: Li, Binkui, et al.
Publicado: (2017) -
Dexmetomidine promotes the activity of breast cancer cells through miR-199a/HIF-1α axis
por: Wen, Gang, et al.
Publicado: (2021) -
MiR199b Suppresses Expression of Hypoxia-Inducible Factor 1α (HIF-1α) in Prostate Cancer Cells
por: Shang, Weiwei, et al.
Publicado: (2013) -
miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8
por: Cui, Yajie, et al.
Publicado: (2018)